Allergy/Asthma News

As cannabis use grows with expanded legalization, a group of experts is investigating allergic reactions to cannabis and developing potential policy and treatment to improve care, according to a review published in Allergy.

A new study linked the Air Quality Index with an increase in exacerbations requiring an ED visit or hospitalization among children with asthma living in Pennsylvania.

Although cases of pediatric food allergy anaphylaxis increased in Australia over the last 2 decades, the rate of increase slowed following the release of new guidelines, according to data in The Journal of Allergy and Clinical Immunology.

A two-step algorithm improved the accuracy and reduced the need for oral food challenges in diagnosing cashew allergy in children, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Risk for COVID-19 hospitalization, ICU admission or death was increased for adults in Scotland with asthma who had a prior hospitalization or required two or more courses of oral corticosteroids in the previous 2 years, researchers reported.

An international team of researchers has developed hair dyes that may be less likely to cause the allergic reactions in users that can occur with traditional dyes, according to a study published in ACS Sustainable Chemistry & Engineering.

Common allergic conditions are more prevalent among nonwhite populations, which are underrepresented in many studies. But multiple strategies can improve their recruitment and retention, improving the value of study results, experts wrote.

Patients with moderate-to-severe asthma or chronic rhinosinusitis with nasal polyps experienced fewer respiratory infections with dupilumab, according to data published in The Journal of Allergy and Clinical Immunology: In Practice.

Mepolizumab reduced polyp size and nasal obstructions in patients with chronic rhinosinusitis with nasal polyps regardless of comorbid asthma or aspirin-exacerbated respiratory disease, according to data from an exploratory analysis.

Oral immunotherapy has shown promise in inducing remission of specific food allergies, with one FDA-approved option available for peanut allergy, but these patients often shoulder the burden of multiple food allergies.